EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brain mGlu5 Is Linked to Cognition and Cigarette Smoking but Does Not Differ From Control in Early Abstinence From Chronic Methamphetamine Use

Megan N McClintick iD, Robert M Kessler, Mark A Mandelkern, Tarannom Mahmoudie, Daicia C Allen, Hilary Lachoff, Jean-Baptiste F Pochon, Dara G Ghahremani, Judah B Farahi, Edwin Partiai, Robert A Casillas, Larissa J Mooney und 2 weitere

International Journal of Neuropsychopharmacology · 2024

DOI: 10.1093/ijnp/pyae031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2024. Verfasst von Megan N McClintick und 13 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Administration of Greater Los Angeles System, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Amphetamine-Related Disorders, Brain, Cigarette Smoking, Methamphetamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The group-I metabotropic glutamate receptor subtype 5 (mGlu5) has been implicated in methamphetamine exposure in animals and in human cognition. Because people with methamphetamine use disorder (MUD) exhibit cognitive deficits, we evaluated mGlu5 in people with MUD and controls and tested its association with cognitive performance.

Methods

Positron emission tomography was performed to measure the total VT of [18F]FPEB, a radiotracer for mGlu5, in brains of participants with MUD (abstinent from methamphetamine for at least 2 weeks, N = 14) and a control group (N = 14). Drug use history questionnaires and tests of verbal learning, spatial working memory, and executive function were administered. Associations of VT with methamphetamine use, tobacco use, and cognitive performance were tested.

Results

MUD participants did not differ from controls in global or regional VT, and measures of methamphetamine use were not correlated with VT. VT was significantly higher globally in nonsmoking vs smoking participants (main effect, P = .0041). MUD participants showed nonsignificant weakness on the Rey Auditory Verbal Learning Task and the Stroop test vs controls (P = .08 and P = .13, respectively) with moderate to large effect sizes, and significantly underperformed controls on the Spatial Capacity Delayed Response Test (P = .015). Across groups, Rey Auditory Verbal Learning Task performance correlated with VT in the dorsolateral prefrontal cortex and superior frontal gyrus.

Conclusion

Abstinent MUD patients show no evidence of mGlu5 downregulation in brain, but association of VT in dorsolateral prefrontal cortex with verbal learning suggests that medications that target mGlu5 may improve cognitive performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphetamine-Related DisordersBrainCigarette SmokingMethamphetaminePositron-Emission TomographyReceptor, Metabotropic Glutamate 5AdultFemaleHumansMaleCentral Nervous System StimulantsCognitionExecutive FunctionNeuropsychological Tests

Stichwörter der Autor:innen

Group-I metabotropic glutamate receptor subtype 5dorsolateral prefrontal cortexpositron emission tomographystimulant use disorderverbal learning

Substanzen

Central Nervous System StimulantsGRM5 protein, humanMethamphetamineReceptor, Metabotropic Glutamate 5

Autor:innen und Institutionen

  • Veterans Administration of Greater Los Angeles System, Los Angeles, California, USA.
  • Semel Institute and Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Physics, University of California Irvine, Irvine, California, USA.

ORCID-Profile: Megan N McClintick

Förderung

  • NIDA NIH HHS

Zitieren

APA

McClintick, M. N., Kessler, R. M., Mandelkern, M. A., Mahmoudie, T., Allen, D. C., Lachoff, H., Pochon, J. F., Ghahremani, D. G., Farahi, J. B., Partiai, E., Casillas, R. A., Mooney, L. J., Dean, A. C., & London, E. D. (2024). Brain mGlu5 Is Linked to Cognition and Cigarette Smoking but Does Not Differ From Control in Early Abstinence From Chronic Methamphetamine Use. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae031

Vancouver

McClintick MN, Kessler RM, Mandelkern MA, Mahmoudie T, Allen DC, Lachoff H, et al. Brain mGlu5 Is Linked to Cognition and Cigarette Smoking but Does Not Differ From Control in Early Abstinence From Chronic Methamphetamine Use. International Journal of Neuropsychopharmacology. 2024. doi:10.1093/ijnp/pyae031

BibTeX
@article{McClintick2024,
  author = {McClintick, Megan N and Kessler, Robert M and Mandelkern, Mark A and Mahmoudie, Tarannom and Allen, Daicia C and Lachoff, Hilary and Pochon, Jean-Baptiste F and Ghahremani, Dara G and Farahi, Judah B and Partiai, Edwin and Casillas, Robert A and Mooney, Larissa J and Dean, Andy C and London, Edythe D},
  title = {Brain mGlu5 Is Linked to Cognition and Cigarette Smoking but Does Not Differ From Control in Early Abstinence From Chronic Methamphetamine Use},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2024},
  doi = {10.1093/ijnp/pyae031}
}
Kostenlos starten →